Crossmark Global Holdings’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,380
Closed -$70K 1361
2020
Q1
$70K Hold
10,380
﹤0.01% 1210
2019
Q4
$121K Sell
10,380
-21,930
-68% -$248K ﹤0.01% 1376
2019
Q3
$333K Sell
32,310
-30
-0.1% -$295 0.01% 1008
2019
Q2
$303K Buy
32,340
+1,430
+5% +$11K 0.01% 1095
2019
Q1
$217K Hold
30,910
0.01% 1278
2018
Q4
$227K Buy
30,910
+15,400
+99% +$129K 0.01% 1233
2018
Q3
$135K Buy
15,510
+30
+0.2% +$306 ﹤0.01% 1560
2018
Q2
$174K Sell
15,480
-30
-0.2% -$358 ﹤0.01% 1548
2018
Q1
$172K Sell
15,510
-1,130
-7% -$14.2K ﹤0.01% 1523
2017
Q4
$212K Sell
16,640
-3,380
-17% -$44.7K 0.01% 1557
2017
Q3
$285K Buy
+20,020
New +$251K 0.01% 1352
2016
Q3
$285K Buy
+20,020
New +$264K 0.01% 1352

Other funds holding CCRN

Crossmark Global Holdings's CCRN Position: Q2 2020 in Review

Crossmark Global Holdings sold out of Cross Country Healthcare (CCRN) in Q2 2020, closing a stake of 10,380 shares — an estimated $70K sold.

Crossmark Global Holdings first reported a position in CCRN in Q3 2016 and held it in 12 quarters. The position peaked at $333K in Q3 2019. 123 funds tracked by Wall St. Rank hold CCRN as of Q2 2020.

  • Crossmark Global Holdings reported no remaining Cross Country Healthcare position as of Q2 2020 after selling out during the quarter.
  • Crossmark Global Holdings sold 10,380 Cross Country Healthcare shares in Q2 2020, an estimated $70K.
  • Crossmark Global Holdings first reported a position in Cross Country Healthcare in Q3 2016 and held it in 12 quarters.
  • Crossmark Global Holdings's Cross Country Healthcare position peaked at $333K in Q3 2019.
  • 123 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2020.

Based on Crossmark Global Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.